期刊文献+

在斋月前、中、后评价2型糖尿病患者甘精胰岛素和格列美脲联合治疗的安全性

Safety evaluation of combined glargine and glimepiride treatment in patients with type 2 diabetes around the period of fasting in Ramadan
原文传递
导出
摘要 在斋月前、中、后期比较甘精胰岛素和格列美脲联合治疗2型糖尿病患者低血糖事件发生的情况。在甘精胰岛素联合格列美脲联合治疗的方案下,斋月前、中、后期低血糖的发生没有差异(P=0.238)。 The incidence of hypoglycemic events in patients with type 2 diabetes around the period of fasting in Ramadan was compared under the treatment with combined insulin glargine and glimepiride. The resuhs showed that the number of hypoglycemic events in patients with type 2 diabetes before, during and after the period of fasting in Ramadan was not different ( P = 0. 238 ).
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2008年第6期647-648,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 斋月 糖尿病 2型 低血糖症 Ramadan Diabetes mellitus, type 2 Hypoglycemia
  • 相关文献

参考文献21

  • 1Aouri M, Haourai-Oukerro F, Mebazaa A, et al. Circadian evolution of serum level of glucose, insulin, cortisol and total proteins in healthy,fasting volunteers. Istanbul, Turkey, Second Interna-tional Congress on Health and Ramadan, 1997 ,p.31.
  • 2Zizi F, Rasoali HA. Serum glucose, bilirubin, calcium, phosphorus, protein and albumin concentrations during Ramadan. Med J I R Iran, 1987,1:38-41.
  • 3Scott TG. The effect of Muslim fast of Ramadan on routine laboratory investigation. King Abdulaziz Med J, 1981,1:23-35.
  • 4Khogheer Y, Sulaiman MI, Al-Fayez SF. Ramadan fasting state of controls. Ann Saudi Med, 1987,7(Suppl. ) :5-6.
  • 5Davidson JC. Muslims, Ramadan and diabetes mellitus. BMJ, 1979, 2:1511-1512.
  • 6Hakkou F, Tazi A, Iraqui L, et al. The observance of Ramadan and its repercussion on gastric secretion. Gastroenterol Clin Biol, 1994,3:190- 194.
  • 7Hojlund K, Wildner-Christensen M, Eshoj O, et al. Reference intervals for glucose, β-cell polypeptides, and counterregulatory factors during prolonged fasting. Am J Physiol Endocrinol Metab, 2001,1: E50-E58.
  • 8Azizi F, Siahkolah B. Ramadan fasting and diabetes mellitus. Int J Ramadan Fasting Res, 1998,2:8-17.
  • 9Riddle MC, Rosenstock J, Gerich J. Insulin Glargine 4002 Study Investigators. The treat-to-target trial-randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care, 2003,26:3080-3086.
  • 10Sahi I, Benard E, Detournay B, et al. the EPIDIAR Study Group: A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care, 2004,27:2306-2311.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部